TY  - GEN
AU  - Koba,Taro
AU  - Minami,Seigo
AU  - Nishijima-Futami,Yu
AU  - Masuhiro,Kentaro
AU  - Kimura,Hiromi
AU  - Futami,Shinji
AU  - Yaga,Moto
AU  - Mori,Masahide
AU  - Kagawa,Hiroyuki
AU  - Uenami,Takeshi
AU  - Kohmo,Satoshi
AU  - Otsuka,Tomoyuki
AU  - Yamamoto,Suguru
AU  - Komuta,Kiyoshi
AU  - Kijima,Takashi
TI  - Phase II trial of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for untreated non-squamous non-small-cell lung cancer
SN  - 1432-0843
PY  - 2019///0625
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Cisplatin
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Induction Chemotherapy
KW  - Kaplan-Meier Estimate
KW  - Lung Neoplasms
KW  - Maintenance Chemotherapy
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Pemetrexed
KW  - Progression-Free Survival
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
UR  - https://doi.org/10.1007/s00280-018-3598-4
ER  -